Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

This multidisciplinary update of the Society of Radiologists in Ultrasound consensus
statement on liver elastography incorporates the large volume of new information available …

Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with an estimated prevalence of up to 30% in the general population and higher …

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of diffuse liver disease. An
accurate estimate of the fat in the liver is important in the diagnostic work-up of patients with …

New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …

Quantitative imaging biomarkers of liver disease measured by using MRI and US are
emerging as important clinical tools in the management of patients with chronic liver disease …

Elastography has emerged as a preferred non-invasive imaging technique for the clinical
assessment of liver fibrosis. Elastography methods provide liver stiffness measurement …

OBJECTIVES: The primary aim of this study was to investigate the value of attenuation
imaging (ATI), a novel ultrasound technique for detection of steatosis, by comparing the …